Clinical trials
Phase 2 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
820 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 12 |
| 2001 | 19 |
| 2002 | 17 |
| 2003 | 30 |
| 2004 | 27 |
| 2005 | 26 |
| 2006 | 39 |
| 2007 | 39 |
| 2008 | 34 |
| 2009 | 26 |
| 2010 | 34 |
| 2011 | 20 |
| 2012 | 18 |
| 2013 | 23 |
| 2014 | 16 |
| 2015 | 28 |
| 2016 | 23 |
| 2017 | 29 |
| 2018 | 39 |
| 2019 | 22 |
| 2020 | 29 |
| 2021 | 32 |
| 2022 | 33 |
| 2023 | 35 |
| 2024 | 40 |
| 2025 | 28 |
| 2026 | 30 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 421 |
| Terminated | 113 |
| Unknown status | 93 |
| Recruiting | 84 |
| Active, not recruiting | 50 |
| Not yet recruiting | 32 |
| Withdrawn | 26 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 50 |
| Gynecologic Oncology Group | 35 |
| Memorial Sloan Kettering Cancer Center | 25 |
| M.D. Anderson Cancer Center | 22 |
| Dana-Farber Cancer Institute | 14 |
| Eli Lilly and Company | 14 |
| AstraZeneca | 11 |
| ARCAGY/ GINECO GROUP | 10 |
| Masonic Cancer Center, University of Minnesota | 9 |
| Mayo Clinic | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 820 |
| Fallopian Tube Neoplasms | 246 |
| Carcinoma, Ovarian Epithelial | 158 |
| Breast Neoplasms | 63 |
| Neoplasms | 57 |
| Endometrial Neoplasms | 54 |
| Recurrence | 44 |
| Uterine Cervical Neoplasms | 44 |
| Sarcoma | 38 |
| Colorectal Neoplasms | 29 |
Trials
Showing 1 to 25 of 820. Each trial links to its page on Pharma Observatory.
720 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.